Making connections: The development of mesencephalic dopaminergic neurons

Developmental Brain Research

Volumn 147, Issue 1-2, 2003, Pages 3-21

  Riddle, Robert ^a   Pollock, Jonathan D ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Axonal guidance; Development; Dopamine neuron; Early neurite specification; Early patterning; Embryogenesis; Growth factor; Mesencephalon; Navigation; Process outgrowth; Proliferation; Substantia nigra; Synapse maturation; Target selection; Transcription factor

Indexed keywords

ALPHA SYNUCLEIN; DOPAMINE; EPHRIN; GROWTH FACTOR; NUCLEAR RECEPTOR RELATED FACTOR 1; PROTEIN; PROTEIN LMX1B; SLIT PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

BRAIN MATURATION; CELL SURVIVAL; CLINICAL RESEARCH; CORPUS STRIATUM; DEVELOPMENTAL STAGE; DOPAMINERGIC NERVE CELL; DRUG ABUSE; DRUG DEPENDENCE; EMBRYO DEVELOPMENT; ENVIRONMENTAL FACTOR; GASTRULATION; GENE EXPRESSION; GENE STRUCTURE; GROWTH; HEREDITY; HOMEOBOX; HUMAN; HYPOTHALAMUS; MESENCEPHALON; NERVE CELL NETWORK; NERVE DEGENERATION; NERVE FIBER; NERVE FIBER REGENERATION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; NUCLEUS ACCUMBENS; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SEROTONINERGIC NERVE CELL; SIGNAL TRANSDUCTION; SYNAPSE; TELENCEPHALON; WITHDRAWAL SYNDROME; ZEBRA FISH;

EID: 1642534464     PISSN: 01653806     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.devbrainres.2003.09.010     Document Type: Review

References (205)

1. Aarnisalo P., Kim C.H., Lee J.W., Perlmann T. Defining requirements for heterodimerization between the retinoid X receptor and the orphan nuclear receptor Nurr1. J. Biol. Chem. 277:2002;35118-35123.
2. Adams K.A., Maida J.M., Golden J.A., Riddle R.D. The transcription factor Lmx1b maintains Wnt1 expression within the isthmic organizer. Development. 127:2000;1857-1867.
3. Ai Y., Markesbery W., Zhang Z., Grondin R., Elseberry D., Gerhardt G.A., Gash D.M. Intraputamenal infusion of GDNF in aged rhesus monkeys: distribution and dopaminergic effects. J. Comp. Neurol. 461:2003;250-261.
4. Airaksinen M.S., Saarma M. The GDNF family: signalling, biological functions and therapeutic value. Nat. Rev., Neurosci. 3:2002;383-394.
5. Akerud P., Alberch J., Eketjall S., Wagner J., Arenas E. Differential effects of glial cell line-derived neurotrophic factor and neurturin on developing and adult substantia nigra dopaminergic neurons. J. Neurochem. 73:1999;70-78.
6. Altabef M., Tickle C. Initiation of dorso-ventral axis during chick limb development. Mech. Dev. 116:2002;19-27.
7. Amara S.G., Sonders M.S. Neurotransmitter transporters as molecular targets for addictive drugs. Drug Alcohol Depend. 51:1998;87-96.
8. Antonopoulos J., Dori I., Dinopoulos A., Chiotelli M., Parnavelas J.G. Postnatal development of the dopaminergic system of the striatum in the rat. Neuroscience. 110:2002;245-256.
9. Asbreuk C.H., Vogelaar C.F., Hellemons A., Smidt M.P., Burbach J.P. CNS expression pattern of Lmx1b and coexpression with ptx genes suggest functional cooperativity in the development of forebrain motor control systems. Mol. Cell. Neurosci. 21:2002;410-420.
10. Bagri A., Marin O., Plump A.S., Mak J., Pleasure S.J., Rubenstein J.L., Tessier-Lavigne M. Slit proteins prevent midline crossing and determine the dorsoventral position of major axonal pathways in the mammalian forebrain. Neuron. 33:2002;233-248.
11. Baloh R.H., Tansey M.G., Golden J.P., Creedon D.J., Heuckeroth R.O., Keck C.L., Zimonjic D.B., Popescu N.C., Johnson E.M. Jr., Milbrandt J. TrnR2, a novel receptor that mediates neurturin and GDNF signaling through Ret. Neuron. 18:1997;793-802.
12. Baloh R.H., Enomoto H., Johnson E.M. Jr., Milbrandt J. The GDNF family ligands and receptors - implications for neural development. Curr. Opin. Neurobiol. 10:2000;103-110.
13. Bayer S.A., Wills K.V., Triarhou L.C., Ghetti B. Time of neuron origin and gradients of neurogenesis in midbrain dopaminergic neurons in the mouse. Exp. Brain Res. 105:1995;191-199.
14. Beck K.D., Valverde J., Alexi T., Poulsen K., Moffat B., Vandlen R.A., Rosenthal A., Hefti F. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature. 373:1995;339-341.
15. Bjoklund A., Lindvall O. Dopamine-containing systems in the CNS. Bjorkland A., Hokfelt T. Classical Transmitters in the CNS: Part I. Handbook of Chemical Neuroanatomy. vol. 2:1984;Elsevier.
16. Bovolenta P., Fernaud-Espinosa I. Nervous system proteoglycans as modulators of neurite outgrowth. Prog. Neurobiol. 61:2000;113-132.
17. Brown R.W., Kolb B. Nicotine sensitization increases dendritic length and spine density in the nucleus accumbens and cingulate cortex. Brain Res. 899:2001;94-100.
18. Burbach J.P., Smits S., Smidt M.P. Transcription factors in the development of midbrain dopamine neurons. Ann. N.Y. Acad. Sci. 991:2003;61-68.
19. Cacalano G., Farinas I., Wang L.C., Hagler K., Forgie A., Moore M., Armanini M., Phillips H., Ryan A.M., Reichardt L.F., Hynes M., Davies A., Rosenthal A. GFRalpha1 is an essential receptor component for GDNF in the developing nervous system and kidney. Neuron. 21:1998;53-62.
20. Callaerts P., Halder G., Gehring W.J. PAX-6 in development and evolution. Annu. Rev. Neurosci. 20:1997;483-532.
21. Castillo S.O., Baffi J.S., Palkovits M., Goldstein D.S., Kopin I.J., Witta J., Magnuson M.A., Nikodem V.M. Dopamine biosynthesis is selectively abolished in substantia nigra/ventral tegmental area but not in hypothalamic neurons in mice with targeted disruption of the Nurr1 gene. Mol. Cell. Neurosci. 11:1998;36-46.
22. Castro D.S., Hermanson E., Joseph B., Wallen A., Aarnisalo P., Heller A., Perlmann T. Induction of cell cycle arrest and morphological differentiation by Nurr1 and retinoids in dopamine MN9D cells. J. Biol. Chem. 276:2001;43277-43284.
23. Chang H., Brown C.W., Matzuk M.M. Genetic analysis of the mammalian transforming growth factor-beta superfamily. Endocr. Rev. 23:2002;787-823.
24. Chao C.C., Ma Y.L., Chu K.Y., Lee E.H. Integrin alphav and NCAM mediate the effects of GDNF on DA neuron survival, outgrowth, DA turnover and motor activity in rats. Neurobiol. Aging. 24:2003;105-116.
25. Charvet I., Hemming F.J., Feuerstein C., Saxod R. Mosaic distribution of chondroitin and keratan sulphate in the developing rat striatum: possible involvement of proteoglycans in the organization of the nigrostriatal system. Dev. Brain Res. 109:1998;229-244.
26. Chen N., Reith M.E. Structure and function of the dopamine transporter. Eur. J. Pharmacol. 405:2000;329-339.
27. Chen B., Fan M., Zhou C.M. LIM homeobox genes family in nervous system. Sheng Li K'o Hsueh Chin Chan. 28:1997;24-28.
28. Chen H., Lun Y., Ovchinnikov D., Kokubo H., Oberg K.C., Pepicelli C.V., Gan L., Lee B., Johnson R.L. Limb and kidney defects in Lmx1b mutant mice suggest an involvement of LMX1B in human nail patella syndrome. Nat. Genet. 19:1998;51-55.
29. Chi C.L., Martinez S., Wurst W., Martin G.R. The isthmic organizer signal FGF8 is required for cell survival in the prospective midbrain and cerebellum. Development. 130:2003;2633-2644.
30. Chiamulera C., Epping-Jordan M.P., Zocchi A., Marcon C., Cottiny C., Tacconi S., Corsi M., Orzi F., Conquet F. Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice. Nat. Neurosci. 4:2001;873-874.
31. Creedon D.J., Tansey M.G., Baloh R.H., Osborne P.A., Lampe P.A., Fahrner T.J., Heuckeroth R.O., Milbrandt J., Johnson E.M. Jr. Neurturin shares receptors and signal transduction pathways with glial cell line-derived neurotrophic factor in sympathetic neurons. Proc. Natl. Acad. Sci. U. S. A. 94:1997;7018-7023.
32. Crossley P.H., Martinez S., Martin G.R. Midbrain development induced by FGF8 in the chick embryo. Nature. 380:1996;66-68.
33. Cygan J.A., Johnson R.L., McMahon A.P. Novel regulatory interactions revealed by studies of murine limb pattern in Wnt-7a and En-1 mutants. Development. 124:1997;5021-5032.
34. Dahlstom A., Fuxe K. Evidence for the existence of monoamine-containing neurones in the central nervous system: I. Demonstration of monoamines in the cell bodies of brain stem neurones. Acta Physiol. Scand. 62:1964;1-55.
35. Dalva M.B., Takasu M.A., Lin M.Z., Shamah S.M., Hu L., Gale N.W., Greenberg M.E. EphB receptors interact with NMDA receptors and regulate excitatory synapse formation. Cell. 103:2000;945-956.
36. Darl T., Dowling J.E. Behavioral screening for cocaine sensitivity in mutagenized zebrafish. Proc. Natl. Acad. Sci. U. S. A. 98:2001;11691-11696.
37. Dauer W., Przedborski S. Parkinson's disease: mechanisms and models. Neuron. 39:2003;889-909.
38. Davis C.A., Joyner A.L. Expression patterns of the homeo box-containing genes En-1 and En-2 and the proto-oncogene int-1 diverge during mouse development. Genes Dev. 2:1988;1736-1744.
39. Dawid I.B., Chitnis A.B. Lim homeobox genes and the CNS: a close relationship. Neuron. 30:2001;301-303.
40. Dean C., Scholl F.G., Choih J., DeMaria S., Berger J., Isacoff E., Scheiffele P. Neurexin mediates the assembly of presynaptic terminals. Nat. Neurosci. 6:2003;708-716.
41. Ding Y.Q., Marklund U., Yuan W., Yin J., Wegman L., Ericson J., Deneris E., Johnson R.L., Chen Z.F. Lmx1b is essential for the development of serotonergic neurons. Nat. Neurosci. 6:2003;933-938.
42. Di Porzio U., Zuddas A., Cosenza-Murphy D.B., Barker J.L. Early appearance of tyrosine hydroxylase immunoreactive cells in the mesencephalon of mouse embryos. Int. J. Dev. Neurosci. 8:1990;523-532.
43. Dreyer S.D., Zhou G., Baldini A., Winterpacht A., Zabel B., Cole W., Johnson R.L., Lee B. Mutations in LMX1B cause abnormal skeletal patterning and renal dysplasia in nail patella syndrome. Nat. Genet. 19:1998;47-50.
44. Fahn S. Description of Parkinson's disease as a clinical syndrome. Ann. N.Y. Acad. Sci. 991:2003;1-14.
45. Failli V., Bachy I., Retaux S. Expression of the LIM-homeodomain gene Lmx1a (dreher) during development of the mouse nervous system. Mech. Dev. 118:2002;225-228.
46. Farkas L.M., Dunker N., Roussa E., Unsicker K., Krieglstein K. Transforming growth factor-beta(s) are essential for the development of midbrain dopaminergic neurons in vitro and in vivo. J. Neurosci. 23:2003;5178-5186.
47. Freed C.R., Greene P.E., Breeze R.E., Tsai W.Y., DuMouchel W., Kao R., Dillon S., Winfield H., Culver S., Trojanowski J.Q., Eidelberg D., Fahn S. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med. 344:2001;710-719.
48. Garda A.L., Echevarria D., Martinez S. Neuroepithelial co-expression of Gbx2 and Otx2 precedes Fgf8 expression in the isthmic organizer. Mech. Dev. 101:2001;111-118.
49. German M.S., Wang J., Chadwick R.B., Rutter W.J. Synergistic activation of the insulin gene by a LIM-homeo domain protein and a basic helix-loop-helix protein: building a functional insulin minienhancer complex. Genes Dev. 6:1992;2165-2176.
50. Gibert J.M. The evolution of engrailed genes after duplication and speciation events. Dev. Genes Evol. 212:2002;307-318.
51. Gouhier C., Chalon S., Aubert-Pouessel A., Venier-Julienne M.C., Jollivet C., Benoit J.P., Guilloteau D. Protection of dopaminergic nigrostriatal afferents by GDNF delivered by microspheres in a rodent model of Parkinson's disease. Synapse. 44:2002;124-131.
52. Granholm A.C., Reyland M., Albeck D., Sanders L., Gerhardt G., Hoernig G., Shen L., Westphal H., Hoffer B. Glial cell line-derived neurotrophic factor is essential for postnatal survival of midbrain dopamine neurons. J. Neurosci. 20:2000;3182-3190.
53. Grimm J.W., Lu L., Hayashi T., Hope B.T., Su T.P., Shaham Y. Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving. J. Neurosci. 23:2003;742-747.
54. Grondin R., Zhang Z., Yi A., Cass W.A., Maswood N., Andersen A.H., Elsberry D.D., Klein M.C., Gerhardt G.A., Gash D.M. Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys. Brain. 125:2002;2191-2201.
55. Guo S., Wilson S.W., Cooke S., Chitnis A.B., Driever W., Rosenthal A. Mutations in the zebrafish unmask shared regulatory pathways controlling the development of catecholaminergic neurons. Dev. Biol. 208:1999;473-487.
56. Guo S., Yamaguchi Y., Schilbach S., Wada T., Lee J., Goddard A., French D., Handa H., Rosenthal A. A regulator of transcriptional elongation controls vertebrate neuronal development. Nature. 408:2000;366-369.
57. Hall F.S., Drgonova J., Goeb M., Uhl G.R. Reduced behavioral effects of cocaine in heterozygous brain-derived neurotrophic factor (BDNF) knockout mice. Synapse. 28:2003;1485-1490.
58. Halladay A.K., Yue Y., Michna L., Widmer D.A., Wagner G.C., Zhou R. Regulation of EphB1 expression by dopamine signaling. Mol. Brain Res. 85:2000;171-178.
59. Hanks M., Wurst W., Anson-Cartwright L., Auerbach A.B., Joyner A.L. Rescue of the En-1 mutant phenotype by replacement of En-1 with En-2. Science. 269:1995;679-682.
60. Hannan A.J., Blakemore C., Katsnelson A., Vitalis T., Huber K.M., Bear M., Roder J., Kim D., Shin H.S., Kind P.C. PLC-beta1, activated via mGluRs, mediates activity-dependent differentiation in cerebral cortex. Nat. Neurosci. 4:2001;282-288.
61. He Z., Wang K.C., Koprivica V., Ming G., Song H.J. Knowing how to navigate: mechanisms of semaphorin signaling in the nervous system. Sci. Signal Transduct. Knowl. Environ. 2002:2002;RE1.
62. Heidet L., Bongers E.M., Sich M., Zhang S.Y., Loirat C., Meyrier A., Broyer M., Landthaler G., Faller B., Sado Y., Knoers N.V., Gubler M.C. In vivo expression of putative LMX1B targets in Nail-Patella Syndrome kidneys. Am. J. Pathol. 163:2003;145-155.
63. Hidalgo-Sanchez M., Alvarado-Mallart R.M. Temporal sequence of gene expression leading caudal prosencephalon to develop a midbrain/hindbrain phenotype. Dev. Dyn. 223:2002;141-147.
64. Hidalgo-Sanchez M., Millet S., Simeone A., Alvarado-Mallart R.M. Comparative analysis of Otx2, Gbx2, Pax2, Fgf8 and Wnt1 gene expressions during the formation of the chick midbrain/hindbrain domain. Mech. Dev. 81:1999;175-178.
65. Hobert O., Westphal H. Functions of LIM-homeobox genes. Trends Genet. 16:2000;75-83.
66. Hoch W. Molecular dissection of neuromuscular junction formation. Trends Neurosci. 26:2003;335-337.
67. Holmberg J., Frisen J. Ephrins are not only unattractive. Trends Neurosci. 25:2002;239-243.
68. Holzschuh J., Hauptmann G., Driever W. Genetic analysis of the roles of Hh, FGF8, and nodal signaling during catecholaminergic system development in the zebrafish brain. J. Neurosci. 23:2003;5507-5519.
69. Horch H.W., Katz L.C. BDNF release from single cells elicits local dendritic growth in nearby neurons. Nat. Neurosci. 5:2002;1177-1184.
70. Horger B.A., Nishimura M.C., Armanini M.P., Wang L.C., Poulsen K.T., Rosenblad C., Kirik D., Moffat B., Simmons L., Johnson E. Jr., Milbrandt J., Rosenthal A., Bjorklund A., Vandlen R.A., Hynes M.A., Phillips H.S. Neurturin exerts potent actions on survival and function of midbrain dopaminergic neurons. J. Neurosci. 18:1998;4929-4937.
71. Horger B.A., Iyasere C.A., Messer C.J., Nestler E.J., Taylor J.R. Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor. J. Neurosci. 19:1999;4110-4122.
72. Horger B.A., Iyasere C.A., Berhow M.T., Messer C.J., Nestler E.J., Taylor J.R. Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor. J. Neurosci. 19:1999;4110-4122.
73. Hwang D.Y., Ardayfio P., Kang U.J., Semina E.V., Kim K.S. Selective loss of dopaminergic neurons in the substantia nigra of Pitx3-deficient aphakia mice. Mol. Brain Res. 114:2003;123-131.
74. Hynes M., Porter J.A., Chiang C., Chang D., Tessier-Lavigne M., Beachy P.A., Rosenthal A. Induction of midbrain dopaminergic neurons by sonic hedgehog. Neuron. 15:1995;35-44.
75. Ikeya M., Lee S.M., Johnson J.E., McMahon A.P., Takada S. Wnt signalling required for expansion of neural crest and CNS progenitors. Nature. 389:1997;966-970.
76. Johansson S., Stromberg I. Guidance of dopaminergic neuritic growth by immature astrocytes in organotypic cultures of rat fetal ventral mesencephalon. J. Comp. Neurol. 443:2002;237-249.
77. Jones L., Fischer I., Levitt P. Nonuniform alteration of dendritic development in the cerebral cortex following prenatal cocaine exposure. Cereb. Cortex. 6:1996;431-445.
78. Jones L.B., Stanwood G.D., Reinoso B.S., Washington R.A., Wang H.Y., Friedman E., Levitt P. In utero cocaine-induced dysfunction of dopamine D1 receptor signaling and abnormal differentiation of cerebral cortical neurons. J. Neurosci. 20:2000;4606-4614.
79. Joyner A.L. Engrailed, Wnt and Pax genes regulate midbrain-hindbrain development. Trends Genet. 12:1996;15-20.
80. Joyner A.L., Martin G.R. En-1 and En-2, two mouse genes with sequence homology to the Drosophila engrailed gene: expression during embryogenesis. Genes Dev. 1:1987;29-38.
81. Joyner A.L., Liu A., Millet S. Otx2, Gbx2 and Fgf8 interact to position and maintain a mid-hindbrain organizer. Curr. Opin. Cell Biol. 12:2000;736-741.
82. Katahira T., Sato T., Sugiyama S., Okafuji T., Araki I., Funahashi J., Nakamura H. Interaction between Otx2 and Gbx2 defines the organizing center for the optic tectum. Mech. Dev. 91:2000;43-52.
83. Kawano H., Horie M., Honma S., Kawamura K., Takeuchi K., Kimura S. Aberrant trajectory of ascending dopaminergic pathway in mice lacking Nkx2.1. Exp. Neurol. 182:2003;103-112.
84. Keller-Peck C.R., Feng G., Sanes J.R., Yan Q., Lichtman J.W., Snider W.D. Glial cell line-derived neurotrophic factor administration in postnatal life results in motor unit enlargement and continuous synaptic remodeling at the neuromuscular junction. J. Neurosci. 21:2001;6136-6146.
85. Kelley A.E., Berridge K.C. The neuroscience of natural rewards: relevance to addictive drugs. J. Neurosci. 22:2002;3306-3311.
86. Kidd T., Brose K., Mitchell K.J., Fetter R.D., Tessier-Lavigne M., Goodman C.S., Tear G. Roundabout controls axon crossing of the CNS midline and defines a novel subfamily of evolutionarily conserved guidance receptors. Cell. 92:1998;205-215.
87. Kim T.E., Lee H.S., Lee Y.B., Hong S.H., Lee Y.S., Ichinose H., Kim S.U., Lee M.A. Sonic hedgehog and FGF8 collaborate to induce dopaminergic phenotypes in the Nurr1-overexpressing neural stem cell. Biochem. Biophys. Res. Commun. 305:2003;1040-1048.
88. Kim K.S., Kim C.H., Hwang D.Y., Seo H., Chung S., Hong S.J., Lim J.K., Anderson T., Isacson O. Orphan nuclear receptor Nurr1 directly transactivates the promoter activity of the tyrosine hydroxylase gene in a cell-specific manner. J. Neurochem. 85:2003;622-634.
89. Kordower J.H., Rosenstein J.M., Collier T.J., Burke M.A., Chen E.Y., Li J.M., Martel L., Levey A.E., Mufson E.J., Freeman T.B., Olanow C.W. Functional fetal nigral grafts in a patient with Parkinson's disease: chemoanatomic, ultrastructural, and metabolic studies. J. Comp. Neurol. 370:1996;203-230.
90. Kruger R., Kuhn W., Muller T., Woitalla D., Graeber M., Kosel S., Przuntek H., Epplen J.T., Schols L., Riess O. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet. 18:1998;106-108.
91. Law S.W., Conneely O.M., DeMayo F.J., O'Malley B.W. Identification of a new brain-specific transcription factor, NURR1. Mol. Endocrinol. 6:1992;2129-2135.
92. Lee S.M., Tole S., Grove E., McMahon A.P. A local Wnt-3a signal is required for development of the mammalian hippocampus. Development. 127:2000;457-467.
93. Leitner M.L., Molliver D.C., Osborne P.A., Vejsada R., Golden J.P., Lampe P.A., Kato A.C., Milbrandt J., Johnson E.M. Jr. Analysis of the retrograde transport of glial cell line-derived neurotrophic factor (GDNF), neurturin, and persephin suggests that in vivo signaling for the GDNF family is GFRalpha coreceptor-specific. J. Neurosci. 19:1999;9322-9331.
94. Levkowitz G., Zeller J., Sirotkin H.I., French D., Schilbach S., Hashimoto H., Hibi M., Talbot W.S., Rosenthal A. Zinc finger protein too few controls the development of monoaminergic neurons. Nat. Neurosci. 6:2003;28-33.
95. Li J.Y., Joyner A.L. Otx2 and Gbx2 are required for refinement and not induction of mid-hindbrain gene expression. Development. 128:2001;4979-4991.
96. Lin L.F., Doherty D.H., Lile J.D., Bektesh S., Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science. 260:1993;1130-1132.
97. Lindahl R., Evces S. Rat liver aldehyde dehydrogenase: II. Isolation and characterization of four inducible isozymes. J. Biol. Chem. 259:1984;11991- 11996.
98. Liu A., Joyner A.L. Early anterior/posterior patterning of the midbrain and cerebellum. Annu. Rev. Neurosci. 24:2001;869-896.
99. Liu A., Joyner A.L. EN and GBX2 play essential roles downstream of FGF8 in patterning the mouse mid/hindbrain region. Development. 128:2001;181-191.
100. Logan C., Hornbruch A., Campbell I., Lumsden A. The role of engrailed in establishing the dorsoventral axis of the chick limb. Development. 124:1997;2317-2324.
101. Loomis C.A., Harris E., Michaud J., Wurst W., Hanks M., Joyner A.L. The mouse engrailed-1 gene and ventral limb patterning. Nature. 382:1996;360-363.
102. Lu B. BDNF and activity-dependent synaptic modulation. Learn. Mem. 10:2003;86-98.
103. Ma P.M. Catecholaminergic systems in the zebrafish: IV. Organization and projection pattern of dopaminergic neurons in the diencephalon. J. Comp. Neurol. 460:2003;13-37.
104. Mace K., Saxod R., Feuerstein C., Sadoul R., Hemming F.J. Chondroitin and keratan sulfates have opposing effects on attachment and outgrowth of ventral mesencephalic explants in culture. J. Neurosci. Res. 70:2002;46-56.
105. Majumdar A., Vainio S., Kispert A., McMahon J., McMahon A.P. Wnt11 and Ret/Gdnf pathways cooperate in regulating ureteric branching during metanephric kidney development. Development. 130:2003;3175-3185.
106. Manier M., Cristina N., Chatellard-Causse C., Mouchet P., Herman J.P., Feuerstein C. Striatal target-induced axonal branching of dopaminergic mesencephalic neurons in culture via diffusible factors. J. Neurosci. Res. 48:1997;358-371.
107. Marin O., Baker J., Puelles L., Rubenstein J.L. Patterning of the basal telencephalon and hypothalamus is essential for guidance of cortical projections. Development. 129:2002;761-773.
108. Martinez S., Wassef M., Alvarado-Mallart R.M. Induction of a mesencephalic phenotype in the 2-day-old chick prosencephalon is preceded by the early expression of the homeobox gene en. Neuron. 6:1991;971-981.
109. Matsunaga E., Katahira T., Nakamura H. Role of Lmx1b and Wnt1 in mesencephalon and metencephalon development. Development. 129:2002;5269-5277.
110. Matsuura N., Lie D.C., Hoshimaru M., Asahi M., Hojo M., Ishizaki R., Hashimoto N., Noji S., Ohuchi H., Yoshioka H., Gage F.H. Sonic hedgehog facilitates dopamine differentiation in the presence of a mesencephalic glial cell line. J. Neurosci. 21:2001;4326-4335.
111. McGeehan A.J., Olive M.F. The mGluR5 antagonist MPEP reduces the conditioned rewarding effects of cocaine but not other drugs of abuse. Synapse. 47:2003;240-242.
112. McGeorge A.J., Faull R.L. The organization of the projection from the cerebral cortex to the striatum in the rat. Neuroscience. 29:1989;503-537.
113. McGrath J., Lintz E., Hoffer B.J., Gerhardt G.A., Quintero E.M., Granholm A.C. Adeno-associated viral delivery of GDNF promotes recovery of dopaminergic phenotype following a unilateral 6-hydroxydopamine lesion. Cell Transplant. 11:2002;215-227.
114. Megason S.G., McMahon A.P. A mitogen gradient of dorsal midline Wnts organizes growth in the CNS. Development. 129:2002;2087-2098.
115. Messer C.J., Eisch A.J., Carlezon W.A. Jr., Whisler K., Shen L., Wolf D.H., Westphal H., Collins F., Russell D.S., Nestler E.J. Role for GDNF in biochemical and behavioral adaptations to drugs of abuse. Neuron. 26:2000;247-257.
116. Moore M.W., Klein R.D., Farinas I., Sauer H., Armanini M., Phillips H., Reichardt L.F., Ryan A.M., Carver-Moore K., Rosenthal A. Renal and neuronal abnormalities in mice lacking GDNF. Nature. 382:1996;76-79.
117. Nakamura S., Ito Y., Shirasaki R., Murakami F. Local directional cues control growth polarity of dopaminergic axons along the rostrocaudal axis. J. Neurosci. 20:2000;4112-4119.
118. Nakamura F., Kalb R.G., Strittmatter S.M. Molecular basis of semaphorin-mediated axon guidance. J. Neurobiol. 44:2000;219-229.
119. Nakanishi S. Metabotropic glutamate receptors: synaptic transmission, modulation, and plasticity. Neuron. 13:1994;1031-1037.
120. Nestler E.J. Molecular neurobiology of addiction. Am. J. Addict. 10:2001;201-217.
121. Nestler E.J. From neurobiology to treatment: progress against addiction. Nat. Neurosci. 5:2002;1076-1079. (Suppl.).
122. Norrholm S.D., Bibb J.A., Nestler E.J., Ouimet C.C., Taylor J.R., Greengard P. Cocaine-induced proliferation of dendritic spines in nucleus accumbens is dependent on the activity of cyclin-dependent kinase-5. Neuroscience. 116:2003;19-22.
123. Nunes I., Tovmasian L.T., Silva R.M., Burke R.E., Goff S.P. Pitx3 is required for development of substantia nigra dopaminergic neurons. Proc. Natl. Acad. Sci. U. S. A. 100:2003;4245-4250.
124. Olanow C.W., Tatton W.G. Etiology and pathogenesis of Parkinson's disease. Annu. Rev. Neurosci. 22:1999;123-144.
125. Oo T.F., Burke R.E. The time course of developmental cell death in phenotypically defined dopaminergic neurons of the substantia nigra. Brain Res. Dev. Brain Res. 98:1997;191-196.
126. Oo T.F., Kholodilov N., Burke R.E. Regulation of natural cell death in dopaminergic neurons of the substantia nigra by striatal glial cell line-derived neurotrophic factor in vivo. J. Neurosci. 23:2003;5141-5148.
127. Paratcha G., Ledda F., Ibanez C.F. The neural cell adhesion molecule NCAM is an alternative signaling receptor for GDNF family ligands. Cell. 113:2003;867-879.
128. Paterson N.E., Semenova S., Gasparini F., Markou A. The mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice. Psychopharmacology (Berl.). 167:2003;257-264.
129. Perlmann T., Jansson L. A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1. Genes Dev. 9:1995;769-782.
130. Perrone-Capano C., Tino A., Amadoro G., Pernas-Alonso R., Di Porzio U. Dopamine transporter gene expression in rat mesencephalic dopaminergic neurons is increased by direct interaction with target striatal cells in vitro. Mol. Brain Res. 39:1996;160-166.
131. Plenz D., Kitai S.T. Regulation of the nigrostriatal pathway by metabotropic glutamate receptors during development. J. Neurosci. 18:1998;4133-4144.
132. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., Nussbaum R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 276:1997;2045-2047.
133. Popik P., Wrobel M. Morphine conditioned reward is inhibited by MPEP, the mGluR5 antagonist. Neuropharmacology. 43:2002;1210-1217.
134. Puelles E., Acampora D., Lacroix E., Signore M., Annino A., Tuorto F., Filosa S., Corte G., Wurst W., Ang S.L., Simeone A. Otx dose-dependent integrated control of antero-posterior and dorso-ventral patterning of midbrain. Nat. Neurosci. 6:2003;453-460.
135. Rajagopalan S., Nicolas E., Vivancos V., Berger J., Dickson B.J. Crossing the midline: roles and regulation of Robo receptors. Neuron. 28:2000;767-777.
136. Reiriz J., Espejo M., Ventura F., Ambrosio S., Alberch J. Bone morphogenetic protein-2 promotes dissociated effects on the number and differentiation of cultured ventral mesencephalic dopaminergic neurons. J. Neurobiol. 38:1999;161-170.
137. Retaux S., Bachy I. A short history of LIM domains (1993-2002): from protein interaction to degradation. Mol. Neurobiol. 26:2002;269-281.
138. Rink E., Wullimann M.F. The teleostean (zebrafish) dopaminergic system ascending to the subpallium (striatum) is located in the basal diencephalon (posterior tuberculum). Brain Res. 889:2001;316-330.
139. Rink E., Wullimann M.F. Connections of the ventral telencephalon and tyrosine hydroxylase distribution in the zebrafish brain (Danio rerio) lead to identification of an ascending dopaminergic system in a teleost. Brain Res. Bull. 57:2002;385-387.
140. Robinson T.E., Kolb B. Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J. Neurosci. 17:1997;8491-8497.
141. Robinson T.E., Kolb B. Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine. Eur. J. Neurosci. 11:1999;1598-1604.
142. Robinson T.E., Kolb B. Morphine alters the structure of neurons in the nucleus accumbens and neocortex of rats. Synapse. 33:1999;160-162.
143. Robinson T.E., Gorny G., Mitton E., Kolb B. Cocaine self-administration alters the morphology of dendrites and dendritic spines in the nucleus accumbens and neocortex. Synapse. 39:2001;257-266.
144. Robinson T.E., Gorny G., Savage V.R., Kolb B. Widespread but regionally specific effects of experimenter-versus self-administered morphine on dendritic spines in the nucleus accumbens, hippocampus, and neocortex of adult rats. Synapse. 46:2002;271-279.
145. Rothberg J.M., Hartley D.A., Walther Z., Artavanis-Tsakonas S. Slit: an EGF-homologous locus of D. melanogaster involved in the development of the embryonic central nervous system. Cell. 55:1988;1047-1059.
146. Rothberg J.M., Jacobs J.R., Goodman C.S., Artavanis-Tsakonas S. Slit: an extracellular protein necessary for development of midline glia and commissural axon pathways contains both EGF and LRR domains. Genes Dev. 4:1990;2169-2187.
147. Sacchetti P., Dwornik H., Formstecher P., Rachez C., Lefebvre P. Requirements for heterodimerization between the orphan nuclear receptor Nurr1 and retinoid X receptors. J. Biol. Chem. 277:2002;35088-35096.
148. Sakurada K., Ohshima-Sakurada M., Palmer T.D., Gage F.H. Nurr1, an orphan nuclear receptor, is a transcriptional activator of endogenous tyrosine hydroxylase in neural progenitor cells derived from the adult brain. Development. 126:1999;4017-4026.
149. Sanchez M.P., Silos-Santiago I., Frisen J., He B., Lira S.A., Barbacid M. Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature. 382:1996;70-73.
150. Saucedo-Cardenas O., Conneely O.M. Comparative distribution of NURR1 and NUR77 nuclear receptors in the mouse central nervous system. J. Mol. Neurosci. 7:1996;51-63.
151. Saucedo-Cardenas O., Quintana-Hau J.D., Le W.D., Smidt M.P., Cox J.J., De Mayo F., Burbach J.P., Conneely O.M. Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. Proc. Natl. Acad. Sci. U. S. A. 95:1998;4013-4018.
152. Scheiffele P. Cell-cell signaling during synapse formation in the CNS. Annu. Rev. Neurosci. 2003.
153. Schuchardt A., D'Agati V., Larsson-Blomberg L., Costantini F., Pachnis V. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature. 367:1994;380-383.
154. Schultz W. Getting formal with dopamine and reward. Neuron. 36:2002;241-263.
155. Seeburg P.H. The molecular biology of mammalian glutamate receptor channels. Trends Neurosci. 16:1993;359-365.
156. Serbedzija G.N., Dickinson M., McMahon A.P. Cell death in the CNS of the Wnt-1 mutant mouse. J. Neurobiol. 31:1996;275-282.
157. Seroogy K.B., Lundgren K.H., Tran T.M., Guthrie K.M., Isackson P.J., Gall C.M. Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs. J. Comp. Neurol. 342:1994;321-334.
158. Shamim H., Mahmood R., Logan C., Doherty P., Lumsden A., Mason I. Sequential roles for Fgf4, En1 and Fgf8 in specification and regionalisation of the midbrain. Development. 126:1999;945-959.
159. Shingo T., Date I., Yoshida H., Ohmoto T. Neuroprotective and restorative effects of intrastriatal grafting of encapsulated GDNF-producing cells in a rat model of Parkinson's disease. J. Neurosci. Res. 69:2002;946-954.
160. Simon H.H., Saueressig H., Wurst W., Goulding M.D., O'Leary D.D. Fate of midbrain dopaminergic neurons controlled by the engrailed genes. J. Neurosci. 21:2001;3126-3134.
161. Simon H.H., Bhatt L., Gherbassi D., Sgado P., Alberi L. Midbrain dopaminergic neurons: determination of their developmental fate by transcription factors. Ann. N.Y. Acad. Sci. 991:2003;36-47.
162. Simpson T.I., Price D.J. Pax6; a pleiotropic player in development. BioEssays. 24:2002;1041-1051.
163. Simpson J.H., Kidd T., Bland K.S., Goodman C.S. Short-range and long-range guidance by slit and its Robo receptors. Robo and Robo2 play distinct roles in midline guidance. Neuron. 28:2000;753-766.
164. Smidt M.P., Asbreuk C.H., Cox J.J., Chen H., Johnson R.L., Burbach J.P. A second independent pathway for development of mesencephalic dopaminergic neurons requires Lmx1b. Nat. Neurosci. 3:2000;337-341.
165. Smith S.M., Ramirez V.D. DARP-36aa selectively promotes survival and morphological development of cultured mesencephalic neurons. J. Neurosci. 23:2003;252-259.
166. Stanwood G.D., Washington R.A., Levitt P. Identification of a sensitive period of prenatal cocaine exposure that alters the development of the anterior cingulate cortex. Cereb. Cortex. 11:2001;430-440.
167. Stanwood G.D., Washington R.A., Shumsky J.S., Levitt P. Nonuniform alteration of dendritic development in the cerebral cortex following prenatal cocaine exposure. Neuroscience. 106:2001;5-14.
168. Stromberg I., Bjorklund L., Forander P. The age of striatum determines the pattern and extent of dopaminergic innervation: a nigrostriatal double graft study. Cell Transplant. 6:1997;287-296.
169. Studer L., Spenger C., Seiler R.W., Altar C.A., Lindsay R.M., Hyman C. Comparison of the effects of the neurotrophins on the morphological structure of dopaminergic neurons in cultures of rat substantia nigra. Eur. J. Neurosci. 7:1995;223-233.
170. Sulzer D., Joyce M.P., Lin L., Geldwert D., Haber S.N., Hattori T., Rayport S. Dopamine neurons make glutamatergic synapses in vitro. J. Neurosci. 18:1998;4588-4602.
171. Sussel L., Marin O., Kimura S., Rubenstein J.L. Loss of Nkx2.1 homeobox gene function results in a ventral to dorsal molecular respecification within the basal telencephalon: evidence for a transformation of the pallidum into the striatum. Development. 126:1999;3359-3370.
172. Sweeney E., Fryer A., Mountford R., Green A., McIntosh I. Nail patella syndrome: a review of the phenotype aided by developmental biology. J. Med. Genet. 40:2003;153-162.
173. Tessier-Lavigne M. Axon guidance by diffusible repellants and attractants. Curr. Opin. Genet. Dev. 4:1994;596-601.
174. Tomozawa Y., Appel S.H. Soluble striatal extracts enhance development of mesencephalic dopaminergic neurons in vitro. Brain Res. 399:1986;111-124.
175. Tornqvist N., Hermanson E., Perlmann T., Stromberg I. Generation of tyrosine hydroxylase-immunoreactive neurons in ventral mesencephalic tissue of Nurr1 deficient mice. Dev. Brain Res. 133:2002;37-47.
176. Ugarte S.D., Lin E., Klann E., Zigmond M.J., Perez R.G. Effects of GDNF on 6-OHDA-induced death in a dopaminergic cell line: modulation by inhibitors of PI3 kinase and MEK. J. Neurosci. Res. 73:2003;105-112.
177. Uhl G.R., Liu Q.R., Walther D., Hess J., Naiman D. Polysubstance abuse-vulnerability genes: genome scans for association, using 1004 subjects and 1494 single-nucleotide polymorphisms. Am. J. Hum. Genet. 69:2001;1290-1300.
178. Ullian E.M., Sapperstein S.K., Christopherson K.S., Barres B.A. Control of synapse number by glia. Science. 291:2001;657-661.
179. Ungerstedt U. Stereotaxic mapping of the monoamine pathways in the rat brain. Acta Physiol. Scand., Suppl. 367:1971;1-48.
180. Unsicker K., Krieglstein K. TGF-betas and their roles in the regulation of neuron survival. Adv. Exp. Med. Biol. 513:2002;353-374.
181. van den M.P., Luk K.C., Ste-Marie L., Montgomery J., Blanchet P.J., Sadikot A.F., Drouin J. Pitx3 is required for motor activity and for survival of a subset of midbrain dopaminergic neurons. Development. 130:2003;2535-2542.
182. Vitalis T., Cases O., Engelkamp D., Verney C., Price D.J. Defect of tyrosine hydroxylase-immunoreactive neurons in the brains of mice lacking the transcription factor Pax6. J. Neurosci. 20:2000;6501-6516.
183. Voorn P., Kalsbeek A., Jorritsma-Byham B., Groenewegen H.J. The pre- and postnatal development of the dopaminergic cell groups in the ventral mesencephalon and the dopaminergic innervation of the striatum of the rat. Neuroscience. 25:1988;857-887.
184. Wallen A., Perlmann T. Transcriptional control of dopamine neuron development. Ann. N.Y. Acad. Sci. 991:2003;48-60.
185. Wallen A., Zetterstrom R.H., Solomin L., Arvidsson M., Olson L., Perlmann T. Fate of mesencephalic AHD2-expressing dopamine progenitor cells in NURR1 mutant mice. Exp. Cell Res. 253:1999;737-746.
186. Wallen A.A., Castro D.S., Zetterstrom R.H., Karlen M., Olson L., Ericson J., Perlmann T. Orphan nuclear receptor Nurr1 is essential for Ret expression in midbrain dopamine neurons and in the brain stem. Mol. Cell. Neurosci. 18:2001;649-663.
187. Wang M.Z., Jin P., Bumcrot D.A., Marigo V., McMahon A.P., Wang E.A., Woolf T., Pang K. Induction of dopaminergic neuron phenotype in the midbrain by sonic hedgehog protein. Nat. Med. 1:1995;1184-1188.
188. Wang L.C., Shih A., Hongo J., Devaux B., Hynes M. Broad specificity of GDNF family receptors GFRalpha1 and GFRalpha2 for GDNF and NTN in neurons and transfected cells. J. Neurosci. Res. 61:2000;1-9.
189. Wang L., Muramatsu S., Lu Y., Ikeguchi K., Fujimoto K., Okada T., Mizukami H., Hanazono Y., Kume A., Urano F., Ichinose H., Nagatsu T., Nakano I., Ozawa K. Delayed delivery of AAV-GDNF prevents nigral neurodegeneration and promotes functional recovery in a rat model of Parkinson's disease. Gene Ther. 9:2002;381-389.
190. Wang Z., Benoit G., Liu J., Prasad S., Aarnisalo P., Liu X., Xu H., Walker N.P., Perlmann T. Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptors. Nature. 423:2003;555-560.
191. Wise R.A. Brain reward circuitry: insights from unsensed incentives. Neuron. 36:2002;229-240.
192. Witta J., Baffi J.S., Palkovits M., Mezey E., Castillo S.O., Nikodem V.M. Nigrostriatal innervation is preserved in Nurr1-null mice, although dopaminergic neuron precursors are arrested from terminal differentiation. Mol. Brain Res. 84:2000;67-78.
193. Wullimann M.F., Rink E. Detailed immunohistology of Pax6 protein and tyrosine hydroxylase in the early zebrafish brain suggests role of Pax6 gene in development of dopaminergic diencephalic neurons. Dev. Brain Res. 131:2001;173-191.
194. Wullimann M.F., Rink E. The teleostean forebrain: a comparative and developmental view based on early proliferation, Pax6 activity and catecholaminergic organization. Brain Res. Bull. 57:2002;363-370.
195. Wurst W., Bally-Cuif L. Neural plate patterning: upstream and downstream of the isthmic organizer. Nat. Rev., Neurosci. 2:2001;99-108.
196. Wurst W., Auerbach A.B., Joyner A.L. Multiple developmental defects in engrailed-1 mutant mice: an early mid-hindbrain deletion and patterning defects in forelimbs and sternum. Development. 120:1994;2065-2075.
197. Xu J., Liu Z., Ornitz D.M. Temporal and spatial gradients of Fgf8 and Fgf17 regulate proliferation and differentiation of midline cerebellar structures. Development. 127:2000;1833-1843.
198. Ye W., Shimamura K., Rubenstein J.L., Hynes M.A., Rosenthal A. FGF and Shh signals control dopaminergic and serotonergic cell fate in the anterior neural plate. Cell. 93:1998;755-766.
199. Yue Y., Widmer D.A., Halladay A.K., Cerretti D.P., Wagner G.C., Dreyer J.L., Zhou R. Specification of distinct dopaminergic neural pathways: roles of the Eph family receptor EphB1 and ligand ephrin-B2. J. Neurosci. 19:1999;2090-2101.
200. Zetterstrom R.H., Solomin L., Mitsiadis T., Olson L., Perlmann T. Retinoid X receptor heterodimerization and developmental expression distinguish the orphan nuclear receptors NGFI-B, Nurr1, and Nor1. Mol. Endocrinol. 10:1996;1656-1666.
201. Zetterstrom R.H., Williams R., Perlmann T., Olson L. Cellular expression of the immediate early transcription factors Nurr1 and NGFI-B suggests a gene regulatory role in several brain regions including the nigrostriatal dopamine system. Mol. Brain Res. 41:1996;111-120.
202. Zetterstrom R.H., Solomin L., Jansson L., Hoffer B.J., Olson L., Perlmann T. Dopamine neuron agenesis in Nurr1-deficient mice. Science. 276:1997;248-250.
203. Zhang X.M., Lin E., Yang X.J. Sonic hedgehog-mediated ventralization disrupts formation of the midbrain-hindbrain junction in the chick embryo. Dev. Neurosci. 22:2000;207-216.
204. Zhou Q.Y., Palmiter R.D. Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic. Cell. 83:1995;1197-1209.
205. Zurn A.D., Widmer H.R., Aebischer P. Sustained delivery of GDNF: towards a treatment for Parkinson's disease. Brain Res. Rev. 36:2001;222-229.